Mink Therapeutics Correlations
INKT Stock | USD 0.72 0.03 4.35% |
The current 90-days correlation between Mink Therapeutics and Bright Minds Biosciences is -0.06 (i.e., Good diversification). The correlation of Mink Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Mink Therapeutics Correlation With Market
Average diversification
The correlation between Mink Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Mink |
Moving together with Mink Stock
0.71 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.61 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
0.63 | RGNX | Regenxbio | PairCorr |
0.67 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.8 | AFMD | Affimed NV | PairCorr |
0.72 | STOK | Stoke Therapeutics | PairCorr |
0.76 | BDTX | Black Diamond Therap | PairCorr |
Moving against Mink Stock
0.65 | OPT | Opthea | PairCorr |
0.51 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.43 | ESLAW | Estrella Immunopharma | PairCorr |
0.35 | PHVS | Pharvaris BV | PairCorr |
0.67 | ABEO | Abeona Therapeutics | PairCorr |
0.54 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.4 | AVTE | Aerovate Therapeutics | PairCorr |
0.32 | TCBPW | TC BioPharm plc | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Mink Stock performing well and Mink Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mink Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DRUG | 49.12 | 28.18 | 2.88 | (0.77) | 4.62 | 9.23 | 1,471 | |||
HPQ | 1.31 | 0.03 | 0.02 | 0.15 | 1.62 | 2.22 | 6.13 | |||
INTC | 2.36 | 0.04 | 0.07 | 0.14 | 2.58 | 6.36 | 18.29 | |||
CVX | 0.90 | 0.07 | 0.02 | 0.22 | 1.05 | 2.21 | 5.13 | |||
KO | 0.68 | (0.15) | 0.00 | (1.28) | 0.00 | 1.11 | 4.00 | |||
TRV | 1.08 | 0.15 | 0.11 | 0.27 | 1.17 | 1.93 | 11.31 | |||
JNJ | 0.61 | (0.10) | 0.00 | (0.37) | 0.00 | 1.40 | 3.25 | |||
JPM | 1.12 | (0.01) | 0.06 | 0.12 | 1.42 | 2.05 | 15.87 | |||
MSFT | 0.90 | (0.03) | (0.04) | 0.07 | 1.49 | 2.09 | 8.19 |
Mink Therapeutics Corporate Management
Kimberly Ha | Head Relations | Profile | |
Joy Zhou | Vice CMC | Profile | |
Marcus Dijk | Chief Officer | Profile | |
Heather Boussios | General Officer | Profile |